dc.contributor.author | Marshall, Peter D. | eng |
dc.contributor.author | Poddar, Sourav | eng |
dc.contributor.author | Tweed, Elizabeth M. | eng |
dc.date.issued | 2006 | eng |
dc.description.abstract | Despite theoretical risks based on animal models given high intravenous doses, glucosamine/chondroitin (1500 mg/1200 mg daily) does not adversely affect short-term glycemic control for patients whose diabetes is well-controlled, or for those without diabetes or glucose intolerance (SOR: A, consistent, good-quality patient-oriented evidence). Some preliminary evidence suggests that glucosamine may worsen glucose intolerance for patients with untreated or undiagnosed glucose intolerance or diabetes (SOR: C, extrapolation from disease-oriented evidence). | eng |
dc.identifier.uri | http://hdl.handle.net/10355/3426 | eng |
dc.language | English | eng |
dc.publisher | Family Physicians Inquiries Network | eng |
dc.relation.ispartofcollection | Clinical Inquiries, 2006 (MU) | eng |
dc.relation.ispartofcommunity | University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network | eng |
dc.relation.ispartofseries | Journal of family practice, 55, no. 12 (December 2006): 1091-1093 | eng |
dc.rights | OpenAccess. | eng |
dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | eng |
dc.subject | glycemic control | eng |
dc.subject | nutritional supplement | eng |
dc.subject | glucose intolerance | eng |
dc.subject.lcsh | Glucosamine -- Therapeutic use | eng |
dc.subject.lcsh | Diabetes | eng |
dc.subject.lcsh | Blood sugar | eng |
dc.title | Do glucosamine and chondroitin worsen blood sugar control in diabetes? | eng |
dc.type | Article | eng |